RayzeBio, Inc. Common Stock
RYZB · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Market Cap | $941 | $967 | $967 |
| - Cash | $129 | $51 | $144 |
| + Debt | $11 | $9 | $1 |
| Enterprise Value | $823 | $926 | $824 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$71 | -$39 | -$7 |
| % Margin | – | – | – |
| Net Income | -$69 | -$29 | -$7 |
| % Margin | – | – | – |
| EPS Diluted | -1.75 | -0.73 | -0.17 |
| % Growth | -139.7% | -329.4% | – |
| Operating Cash Flow | -$52 | -$31 | -$2 |
| Capital Expenditures | -$9 | -$6 | -$0 |
| Free Cash Flow | -$61 | -$37 | -$3 |